Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Benfield, Thomas" or (type any "bookEditor issueEditor" and editor="Benfield, Thomas")

Add to list
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

Sarah Amele, Anastasia Karachalia Sandri, Alison Rodger, Linos Vandekerckhove (UGent) , Thomas Benfield, Ana Milinkovic, Claudine Duvivier, Hans-Jurgen Stellbrink, Helen Sambatakou, Nikoloz Chkhartishvili, et al.

(2022) HIV MEDICINE. 23(6). p.684-692
Add to list
- Journal Article
- A1
- open access
Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials

Cathrine Axfors, Perrine Janiaud, Andreas M. Schmitt, Janneke van’t Hooft, Emily R. Smith, Noah A. Haber, Akin Abayomi, Manal Abduljalil, Abdulkarim Abdulrahman, Yeny Acosta-Ampudia, et al.

(2021) BMC INFECTIOUS DISEASES. 21(1).
Add to list
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? : a post-hoc subgroup analysis of the START trial

Jean-Michel Molina, Birgit Grund, Fred Gordin, Ian Williams, Mauro Schechter, Marcello Losso, Matthew Law, Ernest Ekong, Noluthando Mwelase, Athanasios Skoutelis, et al.

(2018) LANCET HIV. 5(4). p.e172-e180
Add to list
Short-course Toll-like receptor 9 agonist treatment impacts innate immunity and plasma viremia in individuals with human immunodeficiency virus infection

Line Vibholm, Mariane H Schleimann, Jesper F Højen, Thomas Benfield, Rasmus Offersen, Katrine Rasmussen, Rikke Olesen, Anders Dige, Jørgen Agnholt, Judith Grau, et al.

(2017) CLINICAL INFECTIOUS DISEASES. 64(12). p.1686-1695

Academic Bibliography

HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? : a post-hoc subgroup analysis of the START trial

Short-course Toll-like receptor 9 agonist treatment impacts innate immunity and plasma viremia in individuals with human immunodeficiency virus infection

Contents

Support

Contact